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Summary
 
Addition of lipopolysaccharide (LPS) to cells in the form of LPS–soluble (s)CD14 complexes
induces strong cellular responses. During this process, LPS is delivered from sCD14 to the
plasma membrane, and the cell-associated LPS is then rapidly transported to an intracellular
site. This transport appears to be important for certain cellular responses to LPS, as drugs that
block transport also inhibit signaling and cells from LPS-hyporesponsive C3H/HeJ mice fail to
exhibit this transport. To identify the intracellular destination of fluorescently labeled LPS after
its delivery from sCD14 into cells, we have made simultaneous observations of different or-
ganelles using fluorescent vital dyes or probes. Endosomes, lysosomes, the endoplasmic reticu-
lum, and the Golgi apparatus were labeled using Texas red (TR)–dextran, LysoTracker™ Red
DND-99, DiOC6(3), and boron dipyrromethane (BODIPY)–ceramide, respectively. After 30
min, LPS did not colocalize with endosomes, lysosomes, or endoplasmic reticulum in poly-
morphonuclear leukocytes, although some LPS-positive vesicles overlapped with the endoso-
mal marker, fluorescent dextran. On the other hand, LPS did appear to colocalize with two
markers of the Golgi apparatus, BODIPY–ceramide and TRITC (tetramethylrhodamine
isothiocyanate)–labeled cholera toxin B subunit. We further confirmed the localization of LPS
in the Golgi apparatus using an epithelial cell line, HeLa, which responds to LPS–sCD14 com-
plexes in a CD14-dependent fashion: BODIPY–LPS was internalized and colocalized with flu-
orescently labeled Golgi apparatus probes in live HeLa cells. Morphological disruption of the
Golgi apparatus in brefeldin A–treated HeLa cells caused intracellular redistribution of
fluorescent LPS. These results are consistent with the Golgi apparatus being the primary deliv-
ery site of monomeric LPS.
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R
 
ecent work has shown that LPS is delivered to the
membranes of responsive cells by the action of the
 
lipid transport proteins, LPS binding protein (LBP)
 
1
 
 and
CD14 (1). These proteins transport LPS from micelles to
the cell surface by a two-step mechanism. First, LBP cata-
lyzes the transfer of LPS monomers from micelles to a
binding site on soluble (s)CD14 and, in a second step, LPS
monomers are transferred from LPS–sCD14 complexes to
the plasma membranes of cells (2–5). These two steps, bind-
ing of LPS monomers to CD14 and their release into the
membrane, are necessary for sensitive inflammatory responses.
We have recently shown (6) that after binding to the
plasma membrane, monomeric bacterial LPS presented to
PMNs as LPS–sCD14 complexes is rapidly delivered to an
intracellular site. This intracellular movement of LPS ap-
pears to be necessary for certain cellular responses, as agents
that block vesicular transport (lowering temperature to
19
 
8
 
C or addition of wortmannin or cytochalasin D) also
block the integrin-mediated adhesion response of neutro-
phils to LPS (6). None of these conditions blocks cellular
responses to the alternative stimuli, PMA or formyl pep-
tide. Moreover, cells from LPS-hyporesponsive (
 
Lps
 
d
 
) mice
exhibit defective vesicular transport of LPS and ceramide to
a perinuclear site (7), and LPS antagonists block the trans-
port of LPS to a perinuclear site (8).
As responses to LPS appear to involve its transport to a
defined intracellular location, we have sought the identity
of this site. To do this, we observed in parallel the location
of fluorescently labeled LPS and the location of vital stains
for known vesicular compartments in neutrophils and an
epithelial cell line. We show here that most of the internal-
ized boron dipyrromethane (BODIPY)–LPS accumulates
in the Golgi apparatus.
 
1
 
Abbreviations used in this paper: 
 
BODIPY, boron dipyrromethane; CTB,
cholera toxin B subunit; DF, defatted; ER, endoplasmic reticulum; HSA,
 
human serum albumin; LBP, LPS binding protein; 
 
Lps
 
d
 
, LPS hypore-
sponsive; s, soluble; SCAP, SREBP (sterol regulatory element–binding
proteins) cleavage–activating protein; Tf, transferrin; TGN, trans-Golgi
network; TLR, Toll-like receptor; TR, Texas red; TRITC, tetramethyl-
rhodamine isothiocyanate. 
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Materials and Methods
 
Reagents.
 
Aprotinin, defatted (DF)–BSA, and PMA were
purchased from Sigma Chemical Co. Pyrogen-free human serum
albumin (HSA) was obtained from Centeon, Armour, and
Berring Pharmaceutical Co. TNF-
 
a
 
 was purchased from Gen-
zyme Corp. The mAbs used were 26ic (anti-CD14; reference 9),
3C10 (anti-CD14; reference 10), and 44a (anti-CD11b; reference
11), available from American Type Culture Collection (ATCC),
and were purified from ascites fluid by chromatography on pro-
tein G. The anti-CD14 mAb MY4 was purchased from Coulter
Immunology. Dulbecco’s PBS, DME, AIM-V serum-free me-
dium, FCS, penicillin, and streptomycin were purchased from
BioWhittaker. Brefeldin A (BFA) was purchased from Epicentre
Technologies. TRITC-labeled cholera toxin B subunit (TRITC–
CTB) and unlabeled LPS from 
 
Salmonella minnesota
 
 R595 (LPS)
were purchased from List Biological Labs. LysoTracker™ Red
DND-99, BODIPY 558/568–BFA, DiOC6(3), TR–dextran,
BODIPY–fluorescein-like (FL) ceramide, BODIPY 558/568 ce-
ramide, TR–Con A, and TR–transferrin (Tf) were purchased
from Molecular Probes, Inc.
BODIPY–LPS was prepared using LPS from 
 
S. minnesota
 
 us-
ing BODIPY–FL and BODIPY–558/568 amine labeling kits
(BODIPY–LPS; Molecular Probes, Inc.) as previously described
(12). The ratio of BODIPY/LPS molecules was estimated at 1:5.
A 1:1 complex of BODIPY–C5-ceramide with DF–BSA was
prepared as described (13). The complex (5 
 
m
 
M) was prepared in
acid-buffered Eagle’s MEM, pH 7.4, without color indicator.
Recombinant human sCD14 was purified from conditioned me-
dium of Schneider-2 insect cells transfected with cDNA encod-
ing human CD14 and was provided by Dr. R. Thieringer
(Merck Research Laboratories).
To deliver LPS as a monomer, preformed complexes of
BODIPY–LPS with sCD14 were used. To prepare LPS–sCD14
complexes, 100 
 
m
 
g/ml sCD14 was incubated with 5 
 
m
 
g/ml LPS
for 16 h at 37
 
8
 
C. Previous work has shown that under these con-
ditions, all of the LPS forms stoichiometric complexes with mo-
nomeric sCD14 and that these complexes efficiently stimulate
cells and deliver LPS to the membrane (2, 5).
 
Cells.
 
Heparinized blood was obtained by venipuncture
from human healthy volunteers and PMN were purified on neu-
trophil isolation medium (Cardinal Associates, Inc.) according to
the manufacturer’s directions. Cells were suspended in HAP
buffer (Dulbecco’s PBS with 0.5 mg/ml HSA, 0.3 U/ml aproti-
nin, and 3 mM glucose). Human epithelial HeLa cell line was ob-
tained from ATCC and were cultured in DME supplemented
with 10% heat-inactivated FCS, 100 IU/ml penicillin, and 100
 
m
 
g/ml streptomycin.
 
Stimulation and Assay of IL-8 Production.
 
HeLa cells were plated
in 96-well plates at a density of 100,000 cells/well 24 h before
stimulation. The cells were washed extensively with AIM-V se-
rum-free medium and then incubated with various stimuli in
AIM-V medium containing 0.5 mg/ml of HSA. After 5 h, the
supernatants were collected and stored at 
 
2
 
20
 
8
 
C. Samples were
assayed for the presence of IL-8 using a commercially available
human IL-8 ELISA kit (Endogen, Inc.). Results are the mean
values of triplicate wells 
 
6 
 
SEM.
 
Confocal Scanning Laser Microscopy.
 
Purified PMN were washed
in HAP buffer and plated on glass microslides (Carlson Scientific,
Inc.) for 20 min on ice and then exposed to LPS (100 ng/ml) and
fluorescent probes for organelles for 30 min at 37
 
8
 
C. LPS was
added complexed to sCD14. After the incubation, cells were
washed in HAP and examined live by confocal microscopy.
HeLa cells (10
 
6
 
 cells/ml) were washed in DME containing 0.5
mg/ml HSA, incubated with the fluorescent markers at 37
 
8
 
C,
and processed for microscopy.
Analysis of BFA treatment was performed using HeLa cells in-
cubated with TRITC–CTB to visualize the Golgi complex. BFA
(1 
 
m
 
g/ml) was added after labeling of cells for 1 h at 37
 
8
 
C. Cells
were viewed unfixed with a confocal laser scanning system.
Confocal scanning laser microscopy was performed using a
Nikon microscope equipped with a 
 
3
 
100 objective (NA 1.4)
and Bio-Rad MRC 600 or MRC 1024 instrumentation. A dual
wavelength laser was used to excite green (BODIPY or FITC)
and red (BODIPY 558/568, TRITC, or TR) fluorochromes at
488 and 568 nm spectral line of an Ar-Kr laser, respectively. The
fluorescence signals from the two fluorochromes were recorded
sequentially. Confocal images presented were single optical sec-
tions. Images were analyzed using NIH image 1.6 (National In-
stitutes of Health) and LaserSharp (Bio-Rad Labs.) software and
were processed for presentation with Adobe Photoshop 3.0
(Adobe Systems, Inc.) and Corel Draw 6.0 (Corel Corp.).
 
Results
 
LPS Does Not Concentrate in Lysosomes.
 
Lysosomes are
acidic vesicles rich in hydrolytic enzymes and represent the
site of degradation of extracellular macromolecules inter-
nalized by pinocytosis or phagocytosis. It has been shown
that LPS aggregates move at least transiently into an acidic
intracellular compartment of PMN, and deacylation by
acyloxyacyl hydrolase occurs over several hours (14, 15).
We have determined if LPS is internalized into lysosomes
 
Figure 1.
 
Intracellular distribution of LPS and organelle markers in neutrophils. Different markers of organelles were incubated with BODIPY–LPS–
sCD14 for 30 min at 37
 
8
 
C and processed for microscopy. LPS, visualized in green (A–C, E–H) or in red (D), is concentrated in vesicles or tubules. Op-
tical sections of single fluorescently labeled neutrophils are shown in the smaller panels: left, fluorescence for LPS alone; center, the organelle marker
alone; and right, a merged image of both. A merged image of a lower power field is shown in the large panels. (A) Labeling in red of lysosomes with
LysoTracker™ Red DND-99 (50 nM) shows lysosomes to be distributed throughout the cytoplasm in a punctate pattern. Merging magnified areas of
optical sections of fluorescently double-labeled neutrophils shows that LPS vesicles do not overlap with the labeling pattern of lysosomes. (B) Labeling
with TR–dextran (1 mg/ml) reveals endosomes. Although LPS vesicles appear in different sites than endosomes, some can be found associated with en-
dosomes. (C) Labeling in red with TR–Tf (2 
 
m
 
g/ml) shows endosomes of the recycling pathway. Merging magnified areas of optical sections of fluores-
cently double-labeled neutrophils shows that LPS vesicles do not overlap with the labeling pattern of Tf. (D) When BODIPY–LPS labeling is compared
with the ER labeling in green performed with DiOC6(3), LPS fluorescence was distinct from the ER pattern. (E) Similar results were observed with
TR–BFA, a second ER stain. (F) Con A stains ER and the cis-Golgi apparatus. Double-labeled neutrophils with BODIPY–LPS–sCD14 and TR–Con A
(2 
 
m
 
g/ml) show that LPS vesicles partially overlap with structures labeled with Con A. When the patterns of BODIPY–ceramide–BSA (0.5 
 
m
 
M) labeling
(G) or TRITC–CTB (0.1 
 
m
 
g/ml) labeling (H) are compared with the pattern of BODIPY–LPS–sCD14 labeling, the brightly labeled LPS vesicles colo-
calize with the Golgi complex markers. 
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using a fluorescent, freely permeant probe with a high se-
lectivity for acidic organelles, LysoTracker™ Red DND-99
(16). PMN were incubated with BODIPY–LPS (presented
as BODIPY–LPS–sCD14) for 30 min at 37
 
8
 
C in the pres-
ence of LysoTracker™ Red DND-99, and live cells were
observed by confocal microscopy. As previously reported,
LPS appeared in a perinuclear area in a punctate or tubular
pattern (Fig. 1 A; references 6 and 7). In contrast, the fluo-
rescent lysosomes were distributed throughout the cyto-
plasm of PMN, consistent with the numerous azurophilic
granules contained in these cells. The compartment con-
taining the internalized LPS was readily distinguishable
from lysosomes. We cannot exclude the possibility that a
small amount of BODIPY–LPS might be localized within
lysosomes. However, our methods could not distinguish
LPS fluorescence above background autofluorescence in
positions coincident with lysosomes. According to these
observations, the vesicular transport from the plasma mem-
brane does not appear to deliver LPS to lysosomes.
 
LPS Does Not Concentrate in Specific Granules.
 
Activation
of PMN with PMA or TNF-
 
a
 
 induces fusion of specific
granules with the cell membrane and upregulation of extra-
cellular matrix receptors (laminin receptor, vitronectin re-
ceptor, and CD11b/CD18 antigens) on the cell surface,
leading to leukocyte adhesion and extravasation (17).
PMA-stimulated PMN release the contents of both their
specific and azurophilic granules. When PMN were incu-
bated with both PMA and BODIPY–LPS–sCD14 com-
plexes, the autofluorescence of the cells was increased (Fig.
2). However, no modification in the punctate pattern of
LPS fluorescence was observed, suggesting that LPS does
not accumulate in specific granules.
 
LPS Does Not Concentrate in Endosomes.
 
Endosomes are
a structurally diverse population of vacuoles and tubules
serving as sorting intermediates along both the biosynthetic
and endocytic pathways, accumulating intraluminal mem-
brane as they mature. Fluorescent dextran, an hydrophilic
polysaccharide with poly-(
 
a
 
-
 
d
 
-1,6-glucose) linkages, is
rapidly taken up by an endocytic process and moves to
early and late endosomes (18). We have studied the inter-
nalization of a fluid-phase marker (TR–dextran) and LPS
in neutrophils. After 30 min at 37
 
8
 
C, TR–dextran ap-
peared in an heterogeneous assortment of internalized vesi-
cles as expected (Fig. 1 B). BODIPY–LPS, on the other
hand, was concentrated in an organelle distinct from TR–
dextran (Fig. 1 B), suggesting that LPS is not localized in
late endosomes after 30 min. Nevertheless, there was partial
colocalization of LPS vesicles with dextran, as manifested
by the punctate yellow staining in the merged images in
some cells. This partial colocalization was detected most of-
ten near the plasma membrane, suggesting that LPS may
traffic via endosomes containing dextran. Vesicular traffic
involves several steps with distinct kinetics, and intermin-
gling of endocytic markers with LPS after sequential en-
docytic uptake may be dependent on the length of incuba-
tion.
To further resolve the localization of LPS in endosomes,
we examined the intracellular transport of endocytosed
LPS in PMN using Tf to probe the recycling pathway. Flu-
orescent Tf (TR–Tf), which reaches sorting and recycling
endosomes via clathrin-coated pits (19), was localized in a
compartment clearly different from the structure contain-
ing BODIPY–LPS. After 30 min of incubation at 37
 
8
 
C,
TR–Tf was in fact preferentially excluded from the regions
labeled with BODIPY–LPS–sCD14 (Fig. 1 C). These ob-
servations indicate that the trafficking and sorting of LPS in
neutrophils may occur in endosomes containing dextran
and but not Tf.
 
LPS Does Not Concentrate in the Endoplasmic Reticulum.
 
The endoplasmic reticulum (ER) is the largest endomem-
brane system within eukaryotic cells and performs a wide
variety of functions, including calcium uptake and release,
lipid and protein synthesis, protein translocation, folding,
glycosylation, concentration, and export to the Golgi com-
plex. In live cells, the flattened membranous sacs of the ER
can be stained with DiOC6(3), a lipophilic fluorescent dye
(20). AS DiOC6(3) fluoresces green, we performed colo-
calization studies using LPS labeled with a BODIPY probe
that fluoresces in the red part of the spectrum (BODIPY
558/568–LPS). Green or red staining thus illustrates the re-
Figure 2. Intracellular distri-
bution of LPS in neutrophils.
Optical sections of fluorescently
labeled neutrophils are shown.
PMN were incubated with both
PMA (10 ng/ml) and BODIPY–
LPS–sCD14 complexes (left and
right) or BODIPY–LPS–sCD14
complexes only (center) for 30
min at 378C. Comparing magni-
fied cells of optical sections of
neutrophils in the presence or
absence of PMA shows that ve-
sicular LPS labeling was not af-
fected by the released specific
granules, although the autofluo-
rescence of PMN was increased
with PMA stimulation. 
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spective distribution of DiOC6(3)– and BODIPY 558/
568–LPS. Fluorescent LPS was observed in vesicular struc-
tures distinct from the ER (Fig. 1 D), suggesting that there
was no direct transport of LPS to the ER from the cell sur-
face. We have confirmed the absence of LPS in ER using a
second marker. The fluorescently labeled fungal metabolite
BFA intensely stains the ER at concentrations that have no
discernible effects on intracellular transport or other cellular
functions (21). After incubation of PMN with BODIPY–
BFA, LPS was observed in vesicular structures clearly dis-
tinct from those stained with BFA (Fig. 1 E).
Con A binds with high affinity to immature structures
that terminate in glucosyl, mannosyl, or mannosyl and
 
N
 
-acetyl glucosaminyl residues. Con A can label internal
structures by uptake and trafficking and stains the rough
ER and the dilated cisternae of the cis-Golgi apparatus side
(22). Fig. 1 F depicts confocal images of PMN that were
treated with TR–Con A and BODIPY–LPS–sCD14 for 30
min at 37
 
8
 
C. There was partial colocalization of LPS with
Con A in most of the cells, as manifested by the punctate
yellow staining in the merged images. As there was no
colocalization of LPS with the previous ER probes, these
observations were consistent with the finding that LPS
concentrates in the proximal side of the Golgi complex.
 
LPS Colocalizes with Golgi Apparatus Markers.
 
The Golgi
apparatus can be selectively stained with fluorescent ceramide,
which tends to associate preferentially with the trans-Golgi
complex (23). After rapid transport to the Golgi apparatus,
ceramide is metabolized to sphingomyelin, glucosylcer-
amide, and further glycosphingolipids, suggesting that the
pattern of distribution of fluorescently labeled ceramide
may change over time in live cells. To stain cells with this
probe, PMN were incubated first with BODIPY–LPS–
sCD14 complexes for 20 min at 37
 
8
 
C and then BODIPY–
ceramide–BSA was added for 5 min at room temperature.
Cells were washed and subsequently warmed for 2 min at
37
 
8
 
C. Confocal microscopy studies showed that the punc-
tate pattern of labeled cells was very similar with LPS or
ceramide and that the brightly labeled LPS vesicles colocal-
ized with ceramide fluorescence (Fig. 1 G). This strong colo-
calization suggests that LPS accumulates in the Golgi region.
Various glycolipid-binding toxins are internalized from
the cell surface to the Golgi complex, and we have used
CTB as marker of the Golgi apparatus (24). CT consists of
a pentameric B subunit, which binds with high affinity to
ganglioside GM1, and an A subunit, which stimulates ade-
nylate cyclase, resulting in the elevation of cAMP. CTB is
internalized by vesicular transport from the plasma mem-
brane to the Golgi apparatus and persists in this compart-
ment. As previously observed with ceramide, the punctate
pattern of TRITC–CTB was similar to that seen for fluo-
rescent LPS. Merging magnified areas of optical sections of
fluorescently double-labeled PMN confirmed that the
brightly labeled LPS vesicles colocalized with fluorescent
CTB (Fig. 1 H). The specific Golgi subcompartment(s)
containing LPS (or CTB) could not be identified, as they
cannot be resolved by confocal fluorescence microscopy.
 
Quantification of LPS with Lysosomal and Golgi Apparatus
Markers in Neutrophils.
 
Transport of LPS was quantified
by counting fluorescent LPS vesicles, which overlap with
specific probes of the intracellular compartment. Using
LysoTracker™ Red DND-99 and TRITC–CTB as probes
of lysosomes and the Golgi apparatus, respectively, we ob-
served that 74% of LPS vesicles colocalized with CTB
probe in neutrophils (Fig. 3). In contrast, most LPS vesicles
failed to colocalize with the lysosomal marker. These re-
sults suggest that, as seen in Fig. 1, most LPS is directed to
the Golgi apparatus.
 
HeLa Cells Respond to LPS–sCD14 Complexes.
 
Although
LPS appeared to be transported to the Golgi complex,
which is also stained with CTB and ceramide, it was possi-
ble that the probes were in separate compartments that
were unresolvable using confocal microscopy. This is a par-
ticular concern in the centers of the cells, where many or-
ganelles are concentrated. It is even more of an issue with
neutrophils, which are small (12–14 
 
m
 
m in diameter) and
have compact, spheroidal and juxtanuclear Golgi com-
plexes. In contrast, epithelial cells exhibit an extensive,
loose, and perinuclear Golgi apparatus, forming a heteroge-
neous ribbon-like structure connected to several networks
of anastomosed membranous tubules or trans-Golgi net-
work (TGN). The Golgi structure has been thoroughly in-
vestigated in epithelial HeLa cells, which are 100–140 
 
m
 
m
in diameter (25, 26), and we therefore used this cell type to
confirm the localization of LPS within the cell. HeLa cells
take up a low amount of BODIPY–LPS–sCD14 after 30
min at 37
 
8
 
C, as detected by FACScan™ (Becton Dickin-
son; data not shown). Although the uptake of LPS from
LPS–sCD14 complexes is relatively low, HeLa cells do re-
spond to LPS–sCD14 complexes by secretion of IL-8 (Fig.
Figure 3. Quantification of LPS with lysosomal and Golgi apparatus
markers in neutrophils. Cells were labeled in the presence of either
LysoTracker™ Red DND-99 or TRITC–CTB for 30 min at 378C and
processed for microscopy. 15–40 fields of live cells per experiment were
observed, with an average of 5–20 cells per field. All green (LPS-contain-
ing) vesicles in the field were visually assigned as either not colocalized or
colocalized with the red Golgi apparatus or lysosomal marker. Each ex-
periment included data on 101–245 vesicles. Data is presented as the
mean  6  range for two experiments. 
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4 A). This secretion was LPS dose– and CD14-dependent,
as the cytokine response was completely inhibited by two
neutralizing anti-CD14 mAbs, 3C10 (27) and MY4 (Fig. 4
B). IL-8 production was not inhibited by two control
mAbs, 26ic, which recognizes CD14 without inhibiting
binding of LPS or responses towards LPS (4, 28), and 44a,
which binds CD11b molecules (11).
 
Internalized LPS Colocalizes with Golgi Apparatus Markers
in HeLa Cells.
 
We have tested the ability of HeLa cells to
internalize LPS. Cells were labeled for 60 min at 37
 
8
 
C with
BODIPY–LPS and washed before observation by confocal
microscopy. Fluorescent LPS was detected in a collection
of elongate and punctate structures consistent with the lo-
cation of the Golgi (Fig. 5). Cells contained either a com-
pact juxtanuclear reticulum, a structure characteristic of the
Golgi apparatus, or dispersed tubulovesicular membranes,
suggesting mitotic disassembly, fragmentation, and redistri-
bution of the structure in living HeLa cells.
We analyzed in parallel the location of LPS and Golgi
apparatus labels. We observed that the distribution of LPS
overlapped with that of both CTB–FITC and BODIPY–
ceramide (Fig. 5, A and B), confirming that most of the in-
ternalized BODIPY–LPS accumulated in the Golgi appara-
tus. It should be noted that dots of fluorescent LPS not
overlapping with Golgi apparatus probes were also de-
tected, suggesting that a fraction of internalized LPS may
reside in endosomes, resembling the pattern of BODIPY–
LPS observed in PMN (Fig. 1 B). These results are consis-
tent with the Golgi apparatus being the primary delivery
site of LPS by endocytic membrane movement from the
plasma membrane. These observations suggest that the traf-
ficking and sorting of LPS in HeLa cells follows the same
general scheme as in PMN: LPS internalization may occur
through endosomes, initially accessible to the fluid phase
marker dextran, and is further directed into vesicular/tubu-
lar parts of the Golgi apparatus.
 
BFA Causes Redistribution of BODIPY–LPS and Golgi
Apparatus Marker.
 
Treatment of cells with BFA is known
to interfere with coat assembly and results in retrograde
merging of Golgi complex membranes with the ER (29).
BFA blocks membrane export out of the ER and inhibits
vesicle formation. This is due to BFA’s inhibition of nucleo-
tide exchange onto ADP ribosylation factor, a low-molecular-
mass GTP-binding protein that prevents assembly of cyto-
solic coat proteins (including COP I components) onto target
membranes. At the same time, extensive retrograde trans-
port of Golgi complex components to the ER mediated by
growth of Golgi tubules occurs with BFA, leading to the
dilation of the ER and the complete loss of Golgi apparatus
structure. In this study, we investigated the effect of BFA-
induced retrograde membrane transport from Golgi appa-
ratus to ER on LPS vesicles. HeLa cells were first labeled
with both LPS and CTB probes for 1 h at 37
 
8
 
C and
washed and then incubated with BFA for 1 h at 37
 
8
 
C be-
fore observation by confocal microscopy. In BFA-treated
cells, the fluorescent LPS probe was found in scattered/
fragmented cytoplasmic patches (Fig. 6). The disassembly
of the Golgi complex was visualized by the dispersed CTB
fluorescence after BFA treatment. Fluorescent LPS fre-
quently colocalized or was located in proximity to the dis-
persed CTB-positive structures. Our finding indicates that
BFA induced disassembly of the Golgi complex and, in
parallel, redistribution of LPS vesicles. These results con-
firm our conclusion that LPS localizes in the Golgi com-
partment.
 
Discussion
 
Monomeric LPS May Move to the Golgi Apparatus by Retro-
grade Transport.
 
Here we show that biologically active
LPS, delivered to cell membranes as monomers, rapidly
colocalizes with vital stains of the Golgi apparatus. Further-
more, the LPS localization was disrupted after BFA-
induced disruption of the Golgi complex. The colocaliza-
tion was observed in two cell types (PMN and HeLa cells,
Fig. 1, G and H and Fig. 5, A and B), suggesting that traf-
ficking of LPS to the Golgi complex is not unique to leu-
kocytes and may be a general property of cells.
Figure 4. IL-8 secretion by HeLa cells in response to LPS–sCD14
complexes. (A) Monolayers of HeLa cells were incubated for 5 h with
different concentrations of LPS–sCD14 complexes, and the supernatants
were assayed for IL-8 production by ELISA. Results are means 6 SD of
triplicate determinations of a representative experiment repeated three
times. (B) CD14-dependent IL-8 secretion in response to LPS–sCD14
complexes. HeLa cells were incubated with LPS–sCD14 in the presence
or absence of mAbs (10 mg/ml) for 5 h, and the supernatants were assayed
for IL-8 production by ELISA. Results are means 6 SD of triplicate de-
terminations of a representative experiment repeated two times. 
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A major function of the ER and Golgi apparatus is to
package proteins for export, and membranes of these or-
ganelles must therefore move with their protein cargo to-
ward the plasma membrane. Retrieval of the vesicular
membrane is achieved by the process of “retrograde trans-
port,” and we hypothesize that LPS utilizes this process to
achieve movement to the Golgi complex. The pathway of
retrograde transport involves the endosomal compartment
(30, 31) and, in keeping with this hypothesis, we have ob-
served that LPS shows partial overlap with the endosomal
marker, dextran (Fig. 1 B). It is interesting to note that cer-
tain bacterial toxins such as cholera toxin, diphtheria toxin,
 
Pseudomonas
 
 exotoxin A, Shiga toxin, or plant toxins such
as ricin also utilize retrograde transport to reach their target
intracellular compartments (24, 30). Surface-bound toxin
enters cells by endocytosis, with the precise endocytic
route depending on the nature of the receptor. The toxins
are then carried on membranes that recycle between the
plasma membrane and the TGN and between the TGN
and the ER. After reaching the ER, the toxins cross the
membrane and introduce a toxic enzyme into the cyto-
plasm. In a similar fashion, retrograde transport of LPS (en-
dotoxin) via sorting endosomes may be responsible for its
Golgi complex localization and perhaps its biological activ-
ity as well.
As BFA disrupts the Golgi apparatus, it would be of in-
terest to determine if it affects LPS signaling. Unfortu-
nately, BFA is also a potent inhibitor of protein secretion
and, therefore, we could not evaluate a potential effect of
BFA treatment on cytokine production in response to LPS.
Furthermore, previous work (32) has shown that BFA
treatment strongly enhances nuclear factor (NF)-
 
k
 
B trans-
location in HeLa cells, thus precluding a study on LPS-
induced NF-
 
k
 
B activation in BFA-treated cells.
 
Two Fates for Internalized LPS with Opposite Biological
Consequences.
 
We wish to stress that the process observed
here with monomeric LPS differs critically from that stud-
ied by a range of prior authors using LPS aggregates or
whole Gram-negative bacteria (33–40). Indeed, it appears
that there are two distinct routes of LPS trafficking with
two distinct biological outcomes: monomeric LPS is deliv-
ered to the Golgi apparatus, a process associated with cell
stimulation, whereas LPS aggregates are delivered to lyso-
somes, a process not associated with cell stimulation.
 
Delivery of LPS Aggregates to Lysosomes.
 
LPS aggregates
and whole bacteria are clearly delivered to lysosomes (38,
41, 42). Like other particulates, LPS aggregates and whole
bacteria are carried as cargo in the lumen of endosomes or
phagosomes. Delivery to lysosomes results in degradation
of LPS, and the action of one particular lysosomal enzyme
(acyloxyacyl hydrolase; reference 14) results in the transfor-
mation of LPS to a form that antagonizes the cell-stimulat-
ing capacity of complete LPS (43). Receptors for IgG on
macrophages are known to deliver antigen to lysosomes,
and anti-LPS antibodies are known to hasten clearance and
decrease cellular responses to LPS (44). Finally, recent
work indicates that during uptake of LPS aggregates,
mCD14 accompanies LPS into the cell (45).
 
Delivery of LPS Monomers to the Golgi Apparatus.
 
sCD14 delivers LPS to cells not as aggregates but as mono-
mers. In contrast to aggregates, endocytosis of monomeric
LPS occurs after dissociation from mCD14 (45), and it ap-
pears that this LPS is not carried in the lumen of a vesicle
but rather as part of the membrane bilayer. Monomeric
LPS is clearly not transported to lysosomes (Fig. 1 A) but
moves instead to the Golgi complex. Finally, it is clear that
LPS delivered as a monomer is biologically active. Re-
sponses to LPS are optimized when LPS is delivered as
monomers with CD14 (references 2 and 4 and Le Grand,
C.B., N. Lamping, T. Sugiyama, S.D. Wright, and R.
Thieringer, manuscript submitted for publication) or when
fused with the plasma membrane after incorporation into a
viral envelope (46).
The studies reported here use LPS–sCD14 complexes
designed to optimize the efficacy of LPS in cell stimulation
and have resulted in predominant delivery of LPS to the
Golgi complex. At the opposite pole, LPS may be deliv-
ered to cells in complex with IgG in such a way as to min-
Figure 6. Localization of LPS
in HeLa cells is disrupted by
BFA. HeLa cells were incubated
with BODIPY–LPS and
TRITC–CTB for 60 min at
378C in DME with HSA,
washed, and warmed in the ab-
sence or presence of BFA (1 mg/
ml) for 60 min at 378C before
examination by confocal micros-
copy. LPS (green) colocalizes
with CTB (red) and appears in a
perinuclear area before BFA
treatment (yellow on merge pan-
els). Upon BFA exposure, how-
ever, BODIPY–LPS and
TRITC–CTB redistribute to
scattered/fragmented cytoplas-
mic structures. 
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imize cell stimulation (44) and presumably maximize deliv-
ery to lysosomes. We wish to stress that neither condition
closely mimics infection. It appears likely that during
phagocytosis of a live Gram-negative bacterium, the bulk
of LPS will be delivered as vesicular cargo to the lysosome,
and a smaller fraction of LPS may fuse with the plasma
membrane, either by diffusion or the action of the lipid
transfer proteins LBP and CD14. Under these circum-
stances, the bulk of LPS may be destroyed in the lysosomes,
while the cells may simultaneously receive an optimal stim-
ulus from LPS that has fused with the membrane.
 
Role of Internalization in Cell Stimulation.
 
As described
in the Introduction, several lines of evidence suggest that
internalization of LPS may be necessary for at least some
types of signal transduction by LPS. The precise mecha-
nism by which Golgi apparatus internalization affects signal
transduction, however, is not clear at the time of this writ-
ing. Two hypotheses may be entertained. In the first, LPS
may have its effects through modulation or interruption of
vesicular transport per se. It is clear that the lipid composi-
tion of membranes may direct their fate. Transformation of
sphingomyelin to ceramide in the plasma membrane causes
vesiculation (47), and after traffic to the Golgi complex, ce-
ramide may be converted to glucosyl ceramide which, in
turn, is brought back to the plasma membrane (48). LPS
differs from endogenous lipids in that it cannot be metabol-
ically transformed in the Golgi complex and may thereby
interrupt traffic. In support of this hypothesis, accumula-
tion of unfolded proteins in the ER is known to initiate a
stress response called the “ER stress response” (49) or “un-
folded protein response” (50). Activation of NF-
 
k
 
B (51) is
a well known signal induced by LPS and has been reported
to occur during ER stress (52). A second hypothesis is that
proteins involved in sensing infection (pattern recognition
receptors) may be located in the Golgi apparatus or may
need to move to the Golgi apparatus to signal. An example
of the latter case is seen in the proteins that sense choles-
terol concentration (53). SCAP (SREBP cleavage-activating
protein) senses cholesterol concentration and initiates a cascade
of events that activates transcription of genes for cholesterol
 
synthesis. In the presence of adequate levels of cholesterol,
SCAP does not initiate this cascade, and recent data sug-
gests that under these conditions it is sequestered in a pre-
Golgi compartment in an endo H–sensitive form. Low
cholesterol levels trigger both translocation to the Golgi ap-
paratus and initiate the steps leading to cholesterol synthe-
sis. Mutations in SCAP delete in parallel the ability to both
move to the Golgi complex and initiate cholesterol synthe-
sis. In this regard, recent studies have implicated both Toll-
like receptor (TLR)2 and TLR4 as proteins involved in
signaling by LPS (54–59). The subcellular distribution of
TLR protein before and after LPS stimulation will be of
substantial interest.
Whether or not responses are initiated by either of the
mechanisms described above, it is now increasingly clear that
LPS is recognized not as a free monomer but in the context
of its packing in a membrane. E5531 is a synthetic LPS an-
tagonist that resembles LPS but blocks its action in cells
(60). A mirror image of E5531 was synthesized by inversion
of all 13 optically active sites in the molecule, and the enantio-
meric form was an equally active antagonist (Christ, W.J.
1998. Advances in synthetic LPS antagonists. Oral presentation
at Fifth Conference of the International Endotoxin Society,
Santa Fe, NM). This observation argues against the recogni-
tion of LPS by a stoichiometric interaction with a stereo-
specific binding site and rather suggests that the colligative
properties of LPS may play a key role in recognition. In
keeping with this view, we have observed that the ability
of another LPS antagonist (
 
Rhodobacter sphaeroides
 
 [Rs]LPS)
to stimulate cells is dramatically altered by membrane-active
agents. The antagonist activity of RsLPS may be transformed
to agonist by the addition of the membrane-active agent,
chlorpromazine, suggesting an important role for membrane
packing in recognition of LPS. From these considerations,
we are directed to seek recognition proteins that sense LPS
in a bilayer or the properties of a bilayer containing LPS.
The LPS trafficking process we have observed here repre-
sents a cellular response to LPS as part of a membrane and
contributes to an emerging picture of key steps in the in-
nate recognition of LPS.
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